Keck School of Medicine pediatric endocrinologist elected to Institute of Medicine

October 24, 2005

WASHINGTON (Oct. 24)-Francine R. Kaufman, M.D., professor of pediatrics at the Keck School of Medicine of the University of Southern California, was named today as one of 64 new members of the Institute of Medicine of the National Academies.

Kaufman is now one of nine USC faculty members who are part of the Institute of Medicine (IOM). The selections raise the IOM's active membership to 1,461.

"I am truly honored to be elected to the IOM. During the 30 years of my career I have focused on children's health and the emerging epidemics of obesity and diabetes in children, teens and adults, and this is a reflection of that work," says Kaufman, who is head of the division of endocrinology and metabolism at Childrens Hospital Los Angeles. Kaufman also is past president of the American Diabetes Association.

The National Academy of Sciences established the IOM in 1970 to honor professional achievement in the health sciences and to serve as a national resource for independent analysis and recommendations on issues related to medicine, biomedical sciences and health.

With their election, members commit themselves to participate in the work of the IOM, which conducts studies and other activities addressing a broad swath of issues in medical science, health services, public health and health policy.

Examples of current studies include a project to recommend appropriate nutritional standards for foods sold in schools and an evaluation of the nation's system for ensuring the safety of prescription drugs after they have reached the market.

Brian E. Henderson, M.D., dean of the Keck School of Medicine, praised Kaufman's selection. "This honor by the IOM is certainly well deserved and timely because of Dr. Kaufman's work in the area of diabetes and obesity," says Henderson, who also is an IOM member. "Her work relating the two was prescient: She foresaw the coming of this huge social problem we face today."

Henderson notes that Kaufman symbolizes the importance of Childrens Hospital and its faculty to the Keck School. "She and her ideas have been instrumental in energizing the entire Keck School effort in obesity and diabetes research," he says. "This is terrific recognition for what she has done, as well as recognition of the Keck School's obesity program."

USC and Childrens Hospital, where Kaufman is director of the Comprehensive Childhood Diabetes Center, have been partners for 70 years. Kaufman is part of the Keck Diabetes Prevention Initiative, an extensive effort spearheaded by USC and Childrens Hospital to identify and address the interrelated factors that lead to obesity and diabetes in east and south Los Angeles.

Kaufman is not only a physician focusing on the needs of children and teens with diabetes, but she is also a National Institutes of Health-funded researcher, administrator, teacher and advocate for kids.

She has invented numerous products to help children with diabetes and their families, such as the Extendbar, a snack food that keeps blood sugar stable in patients with types 1 or 2 diabetes, as well as an insulin dosage guide. She also was a pioneer in the development of insulin pumps.

In addition to publishing more than 100 articles on types 1 and 2 diabetes and other metabolic disorders in peer-reviewed journals, and presenting hundreds of abstracts at major meetings throughout the world, Kaufman is personally involved in unique grass-roots projects, such as camps for children with diabetes.

She joins nine IOM members at USC and the Keck School: Alexander M. Capron, University Professor of Law and Medicine and Henry W. Bruce Professor of Equity; Clifton O. Dummett, Distinguished Emeritus Professor of Dentistry; Brian E. Henderson, Distinguished Professor of Preventive Medicine and Kenneth T. Norris Jr. Chair in Cancer Prevention; Barbara M. Korsch, professor of pediatrics; Malcolm C. Pike, professor of preventive medicine; Stephen J. Ryan, Grace and Emery Beardsley Chair in Ophthalmology and former Keck School dean; William B. Schwartz, professor of medicine; Harold C. Slavkin, dean of the USC School of Dentistry; and Robert E. Tranquada, Emeritus Professor of Family Medicine and former Keck School dean.

"As the Institute of Medicine celebrates this milestone, it is a great pleasure to welcome these distinguished individuals as members," said IOM President Harvey V. Fineberg. "Election recognizes those who have made major contributions to the advancement of the medical sciences, health care, and public health. It is considered one of the highest honors in these fields."

Current active members elect new members from a slate of candidates nominated for their professional achievement. A diversity of talent among members is assured by the Institute's charter, which requires that at least one-quarter be selected from fields outside the health professions - such as the social and behavioral sciences, law, engineering, and the humanities.

University of Southern California

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to